Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...
The Centers for Medicare & Medicaid Services has proposed a rule expanding Medicare and Medicaid patients’ access to anti-obesity drugs such as GLP-1s.
The Washington Post on MSN6d
FDA approves weight-loss drug Zepbound to treat sleep apneaThe Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...
Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...
After years of feeling unwell and overweight, Richard and Jill Wendt decided to embark on a weight loss journey together and ...
TV star and comedian Katherine Ryan has responded to claims from her teenage daughter that she has been using controversial ...
As the weight-loss drugs become more popular, consumer habits are starting to reflect changing consumption behavior, ...
Eli Lilly will seek to have Mounjaro listed on the scheme this year. If successful, it would mean taxpayer subsidies for the ...
Axios on MSN4d
Use of diabetes and anti-obesity drugs surges nationwideAxios Visuals The number of prescriptions for GLP-1 drugs jumped roughly 10% in 2024, according to insurance claims data provided to Axios by health analytics company PurpleLab. Why it matters: The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback